RAM Pharmaceuticals
Company profile on P2PMarketData. RAM Pharmaceuticals is a pharmaceuticals company based in Lumberton, MS, founded in 2024. It has raised $28.1K through crowdfunding on DealMaker.
RAM Pharmaceuticals is a pharmaceutical company based in Lumberton, Mississippi. Through its RAMdental division, it sells Acyclonine, a compounded medication used by dental providers to relieve pain from oral mucosal conditions such as oral mucositis. Through its RAMtherapeutics division, it is developing Triamdocaine, a therapy designed to relieve severe oral mucositis in cancer patients undergoing radiation or chemotherapy treatment.
Frequently asked questions about RAM Pharmaceuticals
How much funding has RAM Pharmaceuticals raised?
RAM Pharmaceuticals has raised $28.1K through crowdfunding across 2 rounds tracked by P2PMarketData, from 6 investors.
What is RAM Pharmaceuticals' valuation?
RAM Pharmaceuticals had an indicative valuation of $18.1M in its 2025 funding round.
Is RAM Pharmaceuticals profitable?
No. RAM Pharmaceuticals reported a net loss of $33.5K for fiscal year 2025.
How many employees does RAM Pharmaceuticals have?
RAM Pharmaceuticals reported 1 employee for fiscal year 2025.
When was RAM Pharmaceuticals founded?
RAM Pharmaceuticals was founded in November 2024.
Where is RAM Pharmaceuticals based?
RAM Pharmaceuticals is headquartered in Lumberton, Mississippi, United States, and is incorporated in Delaware, United States.
What industry is RAM Pharmaceuticals in?
RAM Pharmaceuticals operates in the Pharmaceuticals industry within the Healthcare sector.